Assessment of the Surveillance Interval at 1 Year After Curative Treatment in Hepatocellular Carcinoma: Risk Stratification.

Conclusions: In high-risk patients, 3-monthly surveillance can prolong survival compared to 6-monthly surveillance. However, in low-risk patients, 3-monthly surveillance might not be beneficial for survival compared to 6-monthly surveillance.
PMID: 29730905 [PubMed - as supplied by publisher]

Source: Gut and Liver - May 9, 2018 Category: Gastroenterology Tags: Gut Liver Source Type: research